The integration of pharmacological and psychological treatments for depression reflects the evidence that their combination produces superior outcomes to either alone in moderate-severe depression — with antidepressants (SSRIs, SNRIs, atypical antidepressants) reducing the neurobiological intensity of depression that makes psychological engagement possible, while psychological therapies (CBT, behavioral activation, interpersonal therapy) address the maintaining mechanisms and build the skills that prevent relapse when medication is discontinued. The optimal combination and sequencing depends on depression severity, specific maintaining factors, individual response patterns, and patient preferences.
Role
Medication-therapy integration is the clinical wisdom that most reduces the false dichotomy between biological and psychological approaches to depression — with the evidence consistently showing that medication without therapy fails to address the cognitive, behavioral, and interpersonal maintaining mechanisms that produce relapse when medication is stopped, while therapy without medication may be inadequate for severe depression whose neurobiological intensity prevents the engagement that therapy requires. Most people access one or the other without the integration — receiving antidepressants from primary care without referral to psychological treatment, or accessing therapy while refusing medication that might enable their full engagement with the therapeutic process.